Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES

Heng-Keang Lim, Nicholas Duczak Jr., Linda Brougham, Michael Elliot, Krupa Patel and Kelvin Chan
Drug Metabolism and Disposition August 2005, 33 (8) 1211-1219; DOI: https://doi.org/10.1124/dmd.104.003475
Heng-Keang Lim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Duczak Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Brougham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Elliot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krupa Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelvin Chan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 33 no. 8 1211-1219
DOI 
https://doi.org/10.1124/dmd.104.003475
PubMed 
15860655

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 23, 2004
  • Accepted April 27, 2005
  • Published online July 13, 2005.

Article Versions

  • Earlier version (April 28, 2005 - 10:29).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Heng-Keang Lim,
  2. Nicholas Duczak, Jr.,
  3. Linda Brougham,
  4. Michael Elliot,
  5. Krupa Patel and
  6. Kelvin Chan
  1. eADME, Drug Metabolism and Pharmacokinetics, Aventis, Bridgewater, New Jersey
  1. Address correspondence to:
    Dr. Heng-Keang Lim, Johnson & Johnson Pharmaceutical Research Institute, Preclinical Pharmacokinetics, Preclinical Drug Evaluation, OCD, K-007, 1001 Route 202 North, P.O. Box 300, Raritan, NJ 08869. E-mail: hlim5{at}prdus.jnj.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201742413
Sep 201722612
Oct 201702322
Nov 20171225
Dec 20170194
Jan 201823316
Feb 201812225
Mar 201802511
Apr 201811424
May 20180174
Jun 201801810
Jul 201801115
Aug 201802111
Sep 20180912
Oct 201801623
Nov 20180159
Dec 20181864
Jan 2019507
Feb 20191048
Mar 20191134
Apr 201928614
May 20191967
Jun 2019616
Jul 20192663
Aug 20192344
Oct 201913109
Nov 20191314
Dec 20193583
Jan 20202265
Feb 20201300
Mar 202019107
May 20201221
Jun 20201302
Jul 20201114
Aug 20201014
Sep 2020722
Oct 20203313
Nov 20201627
Dec 20203146
Jan 202111199
Feb 2021232310
Mar 202140128
Apr 20212678
May 20211384
Jun 20212491
Jul 20211524
Aug 202116111
Sep 20211376
Oct 20212121
Nov 202135410
Dec 20213333
Jan 20223742
Feb 20221747
Mar 20221955
Apr 20222165
May 202216210
Jun 20222631
Jul 202219410
Aug 20223068
Sep 20222364
Oct 202230125
Nov 20222547
Dec 20221722
Jan 20235258
Feb 20232940
Mar 2023957

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (8)
Drug Metabolism and Disposition
Vol. 33, Issue 8
1 Aug 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES

Heng-Keang Lim, Nicholas Duczak, Linda Brougham, Michael Elliot, Krupa Patel and Kelvin Chan
Drug Metabolism and Disposition August 1, 2005, 33 (8) 1211-1219; DOI: https://doi.org/10.1124/dmd.104.003475

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

AUTOMATED SCREENING WITH CONFIRMATION OF MECHANISM-BASED INACTIVATION OF CYP3A4, CYP2C9, CYP2C19, CYP2D6, AND CYP1A2 IN POOLED HUMAN LIVER MICROSOMES

Heng-Keang Lim, Nicholas Duczak, Linda Brougham, Michael Elliot, Krupa Patel and Kelvin Chan
Drug Metabolism and Disposition August 1, 2005, 33 (8) 1211-1219; DOI: https://doi.org/10.1124/dmd.104.003475
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • AKRs and GUSs in Testosterone Disposition
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics